The effect of niacin on sodium, phosphorus, parathyroid hormone (PTH) and vitamin D levels

The effect of niacin on sodium, phosphorus, parathyroid hormone (PTH) and vitamin D levels in hemodialysis patients

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190702044076N2

Enrollment

Registered

2022-11-09

Start date

2022-12-22

Completion date

Unknown

Last updated

2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dialysis. Unspecified complication of foreign body accidentally left in body following kidney dialysis

Interventions

Intervention 1: Intervention group: This group of patients will take 50 mg niacin tablets daily. Intervention 2: Control group: This group of patients will receive placebo tablets similar to niacin t

Eligibility

Sex/Gender

All

Age

15 Years to No maximum

Inclusion criteria

Inclusion criteria: Age over 15 years Phosphorus more than 4.5 At least six months have passed since the start of hemodialysis No change in treatment and hemodialysis protocols in the last two weeks Consent to participate in the study

Exclusion criteria

Exclusion criteria: Pregnancy Known liver diseases Active peptic ulcer disease Taking carbamazepine Drug intolerance

Design outcomes

Primary

Measure	Time frame
Calcium. Timepoint: Before intervention, month 1, 2 and 3. Method of measurement: Blood sampling.;Parathyroid hormone. Timepoint: Before intervention, month 1, 2 and 3. Method of measurement: Blood sampling.;Phosphorus. Timepoint: Before intervention, month 1, 2 and 3. Method of measurement: Blood sampling.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFaranak Sadat Filsous

Shahre-kord University of Medical Sciences

hamidnasri@med.mui.ac.ir+98 31 3778 8907

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 11, 2026